Main

Many patients in need of rehabilitation have stopped coming to physiotherapy centers due to fear of infection with the novel coronavirus.

The 2020 Yigal Alon Prize for Pioneering Excellence was presented to Prof. Elhanan Bar-On, Director of the Center for Disaster Medicine and Humanitarian Response at Sheba.

Working with the ARC Innovation Center, an innovative lab with advanced healthcare information technology will be opened on the hospital campus.

In less than a second, a new easy-to-use saliva test can quickly determine if you are infected with the novel coronavirus.

Acute myeloid leukemia (AML) is one of the most serious, complex cancers. Infection with the novel coronavirus can be deadly for AML patients.

A Sheba clinical trial will begin shortly to test low-dose radiation therapy as a treatment for COVID-19 patients hospitalized with pneumonia and severe respiratory syndrome.

Sheba and Houston Methodist announced their partnership to develop innovative medical projects for the fight against COVID-19.

A review conducted at Sheba of 57 vaccines shows how the current monitoring systems to assess vaccines before approval and track safety after they’re in use are effective and trustworthy.

Sheba opens the revolutionary Mega Lab, an innovative laboratory with automated systems to reduce human error and upgrade patient care.